insights_auto
Why is ORXOY down 33.73%?
Dive Deeperchevron_right
ORXOY:OTCMKTS
Orexo AB - ADR
$0.73
arrow_downward
-33.73%(-0.37) 1D
Oct 6, 9:43:31 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORXOY...
Open
$0.82
High
$0.82
Low
$0.73
Mkt. cap
31.06M
Avg. vol.
349.00
Volume
1.92K
P/E ratio
0.31
52-wk high
$4.05
52-wk low
$0.73
EPS
$2.35
Beta
1.74
Shares outstanding
35.13M
No. of employees
61
Open
$0.82
High
$0.82
Low
$0.73
Mkt. cap
31.06M
Avg. vol.
349.00
Volume
1.92K
P/E ratio
0.31
52-wk high
$4.05
52-wk low
$0.73
EPS
$2.35
Beta
1.74
Shares outstanding
35.13M
No. of employees
61
News stories
From web sources and news partners
TipRanks
·
12 hours ago
Orexo convenes EGM to approve rights issue and capital authorizations
TipRanks
·
12 hours ago
Orexo launches 250 MSEK rights issue to fund pipeline and strengthen finances
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB - ADR
CEONikolaj Sørensen
Employees61
Founded1995
Headquarters-
SectorPharmaceutical industry
Websiteorexo.com